3B BLACKBIO DX LTD. Share Price

NSE: 3BBLACKBIO

₹ 1,276.90

+₹1.20 (0.09%)

Last updated 24 Jul, 2026, 15:29 IST

3B BLACKBIO DX LTD. Share Price Today

As of 25 Jul 2026, 3B BLACKBIO DX LTD. share price is ₹1,276.90. The stock opened at ₹1,260.20, compared to its previous close of ₹1,275.70. During today's trading session, 3B BLACKBIO DX LTD. share price moved in the range of ₹1,260.20 to ₹1,301.80, with an average price of ₹1,281.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,085.00 and a high of ₹1,441.50. On the performance front, 3B BLACKBIO DX LTD. share price has declined by 1.60% over the last six months and is down 1.60% on a year-on-year basis.

₹1,260.20

0.09% up today

₹1,301.80

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 20.27% YoY

Latest Earning

Net Profit TrendUp by 25.67% YoY

Latest Earning

Revenue TrendUp by 50.14% YoY

Stock Performance

OutperformingBeat Nifty by 7.67 % in last 1 month

Shareholding Pattern

PromoterPromoter increased stake by 0.03%

Shareholding Pattern

DIIDII increased stake by 8.54%

Shareholding Pattern

FIIFII decreased stake by 2.54%

3B BLACKBIO DX LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,82,815-₹17,185 (-3.44%)

3 Year

₹5,32,352+₹32,352 (+6.47%)

5 Year

₹5,32,352+₹32,352 (+6.47%)

₹1,020.60₹1,530.80

Circuit Low

Circuit High

₹1,085.00₹1,441.50

52-Week Low

52-Week High

Circuit

₹1,020.60

₹1,530.80

52-week

₹1,085.00

₹1,441.50

Mkt Cap Cr

1,092.32

P/E

18.23

P/B

3.37

ROE

18.06%

D/E

0.00

ROCE

23.58%

Div. Yield

0.39%

EPS(TTM)

57.56

Turnover

0.30

EV/EBITDA

12.26

Net Margin

0.00%

Op. Margin

0.00%

ROA

15.85%

Quick Ratio

0.00

Curr. Ratio

6.18

Mkt Cap Cr

1,092.32

P/E

18.23

P/B

3.37

ROE

18.06%

D/E

0.00

ROCE

23.58%

Div. Yield

0.39%

EPS(TTM)

57.56

Turnover

0.30

EV/EBITDA

12.26

Net Margin

0.00%

Op. Margin

0.00%

ROA

15.85%

Quick Ratio

0.00

Curr. Ratio

6.18

Based on fundamentals, this stock's

Performance

Excellent

3B Blackbio outperforming all market indices

Valuation

Fairly Valued

3B Blackbio appears to be fairly valued compared to its peers

Earnings

Neutral

3B Blackbio earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,27,682.00	63.76	13.48	20.48%	0.32	17.27%	692.92	0.23%	0.70	103.81
Max Healthcare	1,05,470.00	64.89	8.71	14.33%	0.08	13.72%	10.47	0.21%	0.28	7.37
Fortis Healthcare	71,260.50	57.58	6.06	11.31%	0.22	13.36%	6.50	0.13%	0.16	3.05
Aster DM Healthcare	68,387.10	160.00	14.92	8.48%	0.31	10.10%	53.53	0.23%	0.46	5.20
Narayana Hrudayalaya	40,457.30	50.20	8.92	17.76%	0.76	11.42%	127.10	0.23%	0.85	24.77
Global Health	36,944.30	66.67	9.33	14.05%	0.06	15.26%	149.24	0.04%	0.77	18.46
KRISHNA INST OF MED SCI L	32,838.20	135.74	8.76	10.74%	0.63	7.99%	93.54	0.00%	0.46	6.52
Dr. Lal Path Labs	28,275.50	43.61	8.78	21.78%	0.07	27.45%	8.90	1.56%	1.01	30.45
Poly Medicure	16,538.80	51.57	5.32	10.37%	0.08	12.71%	301.18	0.21%	0.53	33.15
Syngene International	16,265.80	49.65	3.25	7.78%	0.05	9.52%	3.34	0.32%	0.67	7.58

3B BLACKBIO DX LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹96.47	₹74.12	₹61.84	₹80.65
Other Income	₹15.08	₹12.53	₹7.26	₹6.90
Total Revenue	₹111.55	₹86.66	₹69.10	₹87.55
Total Expenses	₹47.55	₹42.33	₹33.79	₹44.33
Profit Before Tax	₹64.00	₹44.33	₹35.31	₹43.22
Tax	₹16.31	₹12.23	₹9.37	₹11.02
Profit After Tax	₹47.69	₹32.10	₹25.94	₹32.20
EPS - Basic	₹55.66	₹37.46	₹30.27	₹43.40
EPS - Diluted	₹55.66	₹37.46	₹30.27	₹43.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹64.00	₹44.33	₹35.31	₹43.22
Income before WC changes	₹59.13	₹39.38	₹33.75	₹44.00
Change in Assets	-₹2.11	-₹9.85	-₹2.38	₹30.65
Change in Liabilities	₹1.12	₹8.27	-₹2.14	-₹26.77
Change in WC	-₹0.99	-₹1.59	-₹4.52	₹3.89
Cash flow from Operations	₹43.36	₹26.95	₹20.28	₹37.33
Cash flow from Investing	-₹33.85	-₹20.32	₹14.73	-₹28.44
Cash flow from Financing	-₹3.22	-₹3.63	-₹5.01	-₹15.07
Total Cash Flow	₹6.29	₹3.01	₹30.01	-₹6.19
Cash (Start of the year)	₹62.15	₹59.21	₹28.89	₹35.08
Cash (End of the year)	₹68.83	₹62.15	₹59.21	₹28.89

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹163.53	₹124.71	₹99.82	₹110.55
Current Assets	₹132.19	₹123.40	₹114.24	₹81.54
Total Assets	₹295.72	₹248.10	₹214.06	₹192.09
Current Liabilities	₹18.59	₹17.53	₹14.18	₹16.90
Net Current Asset	₹113.60	₹105.86	₹100.05	₹64.64
Non-Current Liabilities	₹6.13	₹5.10	₹3.96	₹3.11
Equity Capital	₹271.00	₹225.47	₹195.91	₹172.08
Total Equity & Liabilities	₹295.72	₹248.10	₹214.06	₹192.09

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹90.53	₹70.72	₹59.34	₹15.52
Other Income	₹15.03	₹12.32	₹7.26	₹10.09
Total Revenue	₹105.56	₹83.04	₹66.60	₹25.62
Total Expenses	₹41.63	₹36.60	₹30.76	₹17.15
Profit Before Tax	₹63.93	₹46.44	₹35.84	₹8.46
Tax	₹16.37	₹12.23	₹9.42	₹0.46
Profit After Tax	₹47.56	₹34.21	₹26.42	₹8.01
EPS - Basic	₹55.51	₹39.93	₹30.85	₹10.69
EPS - Diluted	₹55.51	₹39.93	₹30.85	₹10.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹63.93	₹46.44	₹35.84	₹8.46
Income before WC changes	₹58.82	₹41.29	₹34.22	₹8.86
Change in Assets	-₹0.70	-₹6.38	-₹1.93	-₹1.34
Change in Liabilities	₹1.19	₹4.39	-₹2.15	₹0.62
Change in WC	₹0.49	-₹1.99	-₹4.08	-₹0.71
Cash flow from Operations	₹44.47	₹28.47	₹21.16	₹7.98
Cash flow from Investing	-₹33.64	-₹20.32	-₹7.80	-₹1.52
Cash flow from Financing	-₹3.07	-₹3.62	-₹2.89	-₹6.31
Total Cash Flow	₹7.76	₹4.53	₹10.46	₹0.14
Cash (Start of the year)	₹54.88	₹50.35	₹39.89	₹1.71
Cash (End of the year)	₹62.63	₹54.88	₹50.35	₹1.85

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹173.07	₹134.23	₹109.21	₹7.20
Current Assets	₹124.05	₹115.59	₹104.46	₹24.40
Total Assets	₹297.12	₹249.82	₹213.67	₹31.60
Current Liabilities	₹18.21	₹17.02	₹13.74	₹5.93
Net Current Asset	₹105.84	₹98.57	₹90.72	₹18.47
Non-Current Liabilities	₹6.13	₹5.02	₹3.83	₹1.75
Equity Capital	₹272.79	₹227.78	₹196.09	₹23.93
Total Equity & Liabilities	₹297.12	₹249.82	₹213.67	₹31.60

* All values are in INR Crore

Qty

Bid

Ask

Qty

Bid Total: 0

Ask Total: 0

Buy orders: 0%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bearish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

56.18

Neutral

ATR (14)

63.12

Neutral

STOCH(9,6)

73.82

Neutral

STOCH RSI (14)

88.12

Bearish

ADX(9)

27.22

Bearish

UO(9)

53.81

Neutral

ROC(12)

9.17

Bullish

WillR(14)

-23.46

Neutral

Period

Simple value

Exponential vaue

1271.04

1269.84

10D

1244.02

1250.74

20D

1211.64

1229.98

50D

1216.21

1216.15

100D

1234.54

About 3B BLACKBIO DX LTD.

ISIN

INE994E01018

Sector Market Cap

₹ 1,092.32 Cr

3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, Next Gen Sequencing (NGS)-based Molecular Diagnostic Kits and Extraction Kits for reliable testing on patient samples. Its products include Oncology and Hematology, Antimicrobial Resistance, Infectious Diseases, Human Genetics, Extraction, and Rapid Antigen Kits. The PCR-based Molecular Diagnostic Kits are commercialized with TRUPCR brand to renowned diagnostics labs across the country. The Company also has a Lateral Flow Assays Vertical and a NGS Assay development division. The lateral flow assays are commercialized under the brand name TRURAPID and the NGS assays are commercialized under the brand name TRUNGS.

3B BLACKBIO DX LTD. Financial Highlights

Revenue: 3B BLACKBIO DX LTD. reported revenue of ₹167.48 crore in FY26 vs ₹111.55 crore in FY25. It showed an increase of 50.14% on a yearly basis.
Operating Profit: 3B BLACKBIO DX LTD. reported an operating profit of ₹76.97 crore in FY26 vs ₹64.00 crore in FY25. It showed an increase of 20.27% on a year-on-year basis.
Net Profit: 3B BLACKBIO DX LTD. reported a net profit of ₹59.93 crore in FY26 vs ₹47.69 crore in FY25. It showed an increase of 25.67% on a yearly basis.

3B BLACKBIO DX LTD. Quarterly Result Highlights

3B BLACKBIO DX LTD. reported revenue of ₹45.58 crore in Mar 2026, compared with ₹55.94 crore in Dec 2025, representing a decrease of 18.52% on a quarter-on-quarter (QoQ) basis.
3B BLACKBIO DX LTD. reported an operating profit of ₹14.65 crore in Mar 2026, compared with ₹26.84 crore in Dec 2025, representing a decrease of 45.42% on a quarter-on-quarter (QoQ) basis.
3B BLACKBIO DX LTD. reported a profit of ₹9.80 crore in Mar 2026, compared with ₹22.44 crore in Dec 2025, reflecting a decrease of 56.33% on a QoQ basis.
The earnings per share (EPS) of 3B BLACKBIO DX LTD. stood at ₹55.66 during Mar 2026.